41st ENMC International Workshop on Congenital Muscular Dystrophy 8-10 March 1996, Naarden, The Netherlands

Neuromuscular Disorders

Volumn 6, Issue 4, 1996, Pages 295-306

  Dubowitz, V ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; LAMININ; MUSCLE PROTEIN;

CHORION VILLUS SAMPLING; CHROMOSOME 6; CLINICAL FEATURE; CONFERENCE PAPER; EPILEPSY; GENE MUTATION; GENETIC LINKAGE; HUMAN; IMAGING; MUSCLE BIOPSY; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; NERVE CONDUCTION; NEUROPATHOLOGY; NONHUMAN; PHENOTYPE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; WALKER WARBURG SYNDROME; WHITE MATTER;

EID: 0030220589     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-8966(96)00358-6     Document Type: Conference Paper

References (35)

1. 1. Dubowitz V. 22nd ENMC Sponsored Workshop on Congenital Muscular Dystrophy, held in Baarn, The Netherlands, 14-16 May 1994. Neuromusc Disord 1994; 4: 75-81.
2. 2. Dubowitz V, Fardeau M. Proc 27th ENMC Sponsored Workshop on Congenital Muscular Dystrophy, 22-24 April 1994, The Netherlands. Neuromusc Disord 1995; 3: 253-258.
3. 3. Toda T, Segawa M, Namura Y et al. Localisation of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q 31 to 32. Nature Genet. 1993; 5: 283-286.
4. 4. Tomé F M S, Evangelista T, Leclerc A, et al. Congenital muscular dystrophy with merosin deficiency. CR Acad Sci (Paris) 1994; 317: 351-353.
5. 5. Philpot J, Sewry C, Pennock J, Dubowitz V. Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle. Neuromusc Disord 1995; 5: 301-305.
6. 5A. Herrmann R, Sträub V, Meyer K, et al. Congenital muscular dystrophy with laminin α2-chain deficiency: correlation of clinical findings and muscle immunocytochemistry and characterisation of a new milder phenotype. Eur J. Pediatr (in press).
7. 5B. Fardeau M, Tomé F M S, Helbling-Leclerc A, et al. Dystrophie musculaire congénitale avec déficience en mérosine: analyse clinique, histopathologique et génétique. R Neurol 1996; 152: 11-91.
8. 6. Sunada Y, Edgar T S, Lotz B P, Rust R S, Campbell K P. Merosin-negative congenital muscular dystrophy associated with extensive brain abnormalities. Neurology 1995; 45: 2084-2089.
9. 7. Pini A, Merlini L, Tomé F M S, Chevally M, Gobbi G. Merosin-negative congenital muscular dystrophy, occipital epilepsy with periodic spasms and focal cortical dysplasia. Report of three Italian cases in two families. Brain Dev. (in press).
10. 8. Leyten Q H1, Barth P G, Gabreëls F J M, et al. Congenital muscular dystrophy and severe central nervous system atrophy in two siblings. Acta Neuropathol 1995; 90: 650-656.
11. 8A. Shorer Z, Philpot J, Muntoni F, Sewry C, Dubowitz V. Demyelinating peripheral neuropathy in merosindeficient congenital muscular dystrophy. J Child Neurol 1995; 10: 472-475.
12. 9. Helbling-Leclerc A, Topaloglu H, Tomé F M S et al. Readjusting the localisation of merosin (laminin α2-chain) deficient congenital muscular dystrophy locus on chromosome 6q2. C R Acad Sci (Paris) 1995; 318: 1245-1252.
13. 9A. Helbling-Leclerc A, Zhang X, Topaloglu H et al. Mutations in the laminin α2-chain gene (LAMA2) cause merosin-deficient congenital dystrophy. Nature Genet 1995; 11: 216-218.
14. 10. Nissinen M, Helbling-Leclerc A, Zhang X et al. Substitution of a conserved cysteine-996 in a cysteine-rich motif of the laminin α2-chain in congenital muscular dystrophy. Am J Hum Genet 58 (in press).
15. 11. Muntoni F, Sewry C, Wilson L, et al. Prenatal diagnosis of congenital muscular dystrophy. The Lancet 1995; 345: 591.
16. 12. Engvall E. Wewer UM. The domains of laminin. J Cell Biochem 1996.
17. 13. Burgeson R E, Chiquet M, Deutzmann R et al. A new nomenclature for laminins. Matrix Biol 1994; 14: 209-211.
18. 14. Xu H, Wu X R, Wewer U M, Engvall E. Murine muscular dystrophy caused by a mutation in the laminin α2 (LAMA2) gene. Nature Genet 1994; 8: 297-302.
19. 15. Yamada H, Tomé F M S, Higuchi I, et al. Laminin abnormality in severe childhood autosomal recessive muscular dystrophy. Lab Invest 1995; 72: 715-722.
20. 16. Wewer U M, Durkin M E, Zhang X, et al. Laminin β2 and adhalin deficiency in the skeletal muscle of Walker-Warburg syndrome (cerebro-ocular dysplasia-muscular dystrophy). Neurology 1995; 45: 2099-2101.
21. 17. Matsumura K, Yamada H, Shimizu T, Campbell K P. Differential expression of dystrophin, utrophin and dystrophin-associated proteins in peripheral nerve. FEBS Lett 1993; 334: 281-285.
22. 18. Yamada H, Shimizu T, Tanaka T, Campbell K P, Matsumura K. Dystroglycan is binding protein of laminin and merosin in peripheral nerve. FEBS Lett 1994; 352: 49-53.
23. 19. Yamada H, Chiba A, Endo T, et al. Characterisation of dystroglycan laminin interaction in peripheral nerve. J Neurochem 1996; 66: 1518-1524
24. 20. Yamada H, Denzer A, Hori H, et al. Dystroglycan is a dual receptor of agrin and laminin-2 in Schwann cell membrane. J Biol Chem (in press).
25. 21. Yamada H, Hori H, Tanaka T, et al. Secretion of laminin α2 chain in cerebrospinal fluid. FEBS Lett. 1995; 376: 37-40
26. 22. Villanova M, Malandrini A, Toti P, et al. Localisation of merosin in the normal human brain: implications for congenital muscular dystrophy with merosin deficiency. J Submicroscop Cytol Pathol 1996; 28: 1-3.
27. 23. Sewry C A, Philpot J, Sorokin L M, et al. Diagnosis of merosin (Laminin α2) deficient congenital muscular dystrophy by skin biopsy. The Lancet 1996, 347: 582-548.
28. 24. Sewry C A, Chevallay M, Tomé F M S. Expression of laminin subunits in human fetal skeletal muscle. Histochem J. 1995; 27: 497-504.
29. 25. North K N, Beggs A H. Deficiency of skeletal muscle isoform of α-actinin (α-actinin 3) in merosin-positive congenital muscular dystrophy. Neuromusc Disord (in press)
30. 26. Voit T, Muntoni F, Meyer K, et al. Preserved merosin expression in skeletal muscle distinguishes Walker-Warburg syndrome from Fukuyama muscular dystrophy and merosin-deficient congenital muscular dystrophy. Neuropediatrics 1995; 26: 148-155.
31. 27. Dobyns W B, Patton M A, Stratton J M. Cobblestone lissencephaly with normal eyes and muscle. Neuropediatrics 1996; 2: 70-75.
32. 28. Toda T, Ikegawa S, Okui I, et al. Refined mapping of a gene responsible for Fukuyama type congenital muscular dystrophy: evidence for strong linkage disequilibrium. Am J Hum Genet 1994; 55: 946-950.
33. 29. Arahata K, Ishii H, Hayshi Y K, et al. Basal lamina (BL) abnormality in Fukuyama congenital muscular dystrophy: an electron microscopic observation. Brain Pathol 1994; 4: 428.
34. 30. Arahata K, Hayashi Y K, Koga R, et al. Laminin in animal models for muscular dystrophy: defect of laminin M in skeletal and cardiac muscles and peripheral nerve of the homozygous dystrophic dy/dy mice. Proc Japan Acad 1993; 69: 259-264.
35. 31. Nakano I, Funahashi M, Takada K, Toda T. Are breaches in the glia limitance the primary cause of the micropolygryia in Fukuyama-type congenital muscular dystrophy (FCMD)? - pathological study of the cerebral context of an FCMD fetus. Acta Neuropathol 1996; 91: 313-321.